Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

NK10 Inhibitors

NK10 inhibitors are a class of chemical compounds that target the NK10 receptor, a protein involved in cellular signaling pathways. These inhibitors are designed to modulate the activity of the NK10 receptor by either blocking or altering its interactions with other molecular partners. NK10, like other receptors of its kind, is primarily found on the surface of certain cell types, where it plays a role in regulating cell communication, growth, and other intracellular processes. The inhibition of NK10 activity can disrupt normal receptor-ligand binding, leading to downstream effects on signaling cascades that regulate a variety of cellular functions.

Structurally, NK10 inhibitors typically contain functional groups capable of interacting with key residues within the NK10 binding pocket. These interactions often rely on hydrophobic forces, hydrogen bonding, or van der Waals interactions to achieve specificity. The molecular design of NK10 inhibitors can vary, with some incorporating rigid, planar cores to fit within the receptor's active site, while others may feature more flexible scaffolds to enhance binding affinity. Modifications to the inhibitor's structure, such as changes to its polar or hydrophobic regions, can significantly affect its ability to bind NK10 and inhibit its function. Advances in chemical design have allowed for the development of highly selective inhibitors, which can be used to study the role of NK10 in various biological systems. These molecules serve as essential tools in understanding the intricacies of receptor-mediated signaling processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$45.00
$111.00
61
(1)

BCR-ABL kinase inhibitor that can suppress kinase activity, which may be involved in the activation or function of NK10.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

EGFR inhibitor that can interfere with tyrosine kinase signaling, potentially affecting pathways that regulate NK10.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF kinase inhibitor that can inhibit multiple kinases, potentially altering signaling cascades involving NK10.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Receptor tyrosine kinase inhibitor that can affect multiple signaling pathways, and thus could modulate NK10 activity.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

SRC-family kinase inhibitor that can change kinase signaling, possibly affecting NK10-mediated pathways.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor that can disrupt tyrosine kinase signaling, possibly implicating NK10 functionality.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Multi-kinase inhibitor that can affect VEGF signaling and potentially other pathways related to NK10.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

VEGFR inhibitor that can impact signaling pathways, possibly affecting NK10's regulatory functions.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL inhibitor that can disrupt kinase activity, potentially affecting pathways involving NK10.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

MET, RET, and VEGFR2 inhibitor that can modulate multiple signaling pathways, which may influence NK10's role.